Iron Chelation In Transfusion-Dependent Patients With Low-To Intermediate-1-Risk Myelodysplastic Syndromes Response

ANNALS OF INTERNAL MEDICINE(2020)

引用 3|浏览3
暂无评分
摘要
Iron overload in transfusion-dependent patients with myelodysplastic syndrome (MDS) can lead to poorer clinical outcomes. The effectiveness of iron chelation therapy in patients with lower-risk MDS...
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要